Hang Tong

Dr. Hang Tong


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
HTHang Tong
Hang Tong
HYHubin Yin
Hubin Yin
MHMohammad Arman Hossain
Mohammad Arman Hossain
YWYiyang Wang
Yiyang Wang
FWFeixiang Wu
Feixiang Wu
WHWeiyang He
Weiyang He

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YWYiyang Wang
Yiyang Wang
YHYanzhu Hu
Yanzhu Hu
HWHaoming Wang
Haoming Wang
NLNingyuan Liu
Ningyuan Liu
LLLei Luo
Lei Luo
QZQiang Zhou
Qiang Zhou
Established studies proved that mechanical compression loading had multiple effects on the biological behavior of the intervertebral disc (IVD). However, the regulating mechanism involved in this process remains unclear. The current study is aimed at exploring the potential bioregulators and signaling pathways involved in the compression‐associated biological changes of nucleus pulposus (NP) cells. Tandem mass tag‐ (TMT‐) based quantitative proteomics was exerted to analyze the differentially expressed proteins (DEPs) and signal pathways among the different groups of NP cells cultured under noncompression, low‐compression (LC), and high‐compression (HC) loading. Eight potential protective bioregulators for the NP cell survival under different compression loading were predicted by the proteomics, among which macrophage migration inhibitory factor (MIF) and oxidative stress‐related pathways were selected for further evaluation, due to its similar function in regulating the fate of the cartilage endplate‐ (CEP‐) derived cells. We found that deficiency of MIF accentuates the accumulation of ROS, mitochondrial dysfunction, and senescence of NP cells under overloaded mechanical compression. The potential molecular mechanism involved in this process is related to the mitophagy regulating role of MIF. Our findings provide a better understanding of the regulatory role of mechanical compression on the cellular fate commitment and matrix metabolism of NP, and the potential strategies for treating disc degenerative diseases via using MIF‐regulating agents.

10 January 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
TLTinghao Li
Tinghao Li
HTHang Tong
Hang Tong
JZJunlong Zhu
Junlong Zhu
ZQZijia Qin
Zijia Qin
SYSiwen Yin
Siwen Yin
WHWeiyang He
Weiyang He
The clear cell renal cell carcinoma (ccRCC) is not only a malignant disease but also an energy metabolic disease, we aimed to identify a novel prognostic model based on glycolysis-related long non-coding RNA (lncRNAs) and explore its mechanisms. With the use of Pearson correlation analysis between the glycolysis-related differentially expressed genes and lncRNAs from The Cancer Genome Atlas (TCGA) dataset, we identified three glycolysis-related lncRNAs and successfully constructed a prognostic model based on their expression. The diagnostic efficacy and the clinically predictive capacity of the signature were evaluated by univariate and multivariate Cox analyses, Kaplan–Meier survival analysis, and principal component analysis (PCA). The glycolysis-related lncRNA signature was constructed based on the expressions of AC009084.1, AC156455.1, and LINC00342. Patients were grouped into high- or low-risk groups according to risk score demonstrated significant differences in overall survival (OS) period, which were validated by patients with ccRCC from the International Cancer Genome Consortium (ICGC) database. Univariate Cox analyses, multivariate Cox analyses, and constructed nomogram-confirmed risk score based on our signature were independent prognosis predictors. The CIBERSORT algorithms demonstrated significant correlations between three-glycolysis-related lncRNAs and the tumor microenvironment (TME) components. Functional enrichment analysis demonstrated potential pathways and processes correlated with the risk model. Clinical samples validated expression levels of three-glycolysis-related lncRNAs, and LINC00342 demonstrated the most significant aberrant expression. in vitro, the general overexpression of LINC00342 was detected in ccRCC cells. After silencing LINC00342, the aberrant glycolytic levels and migration abilities in 786-O cells were decreased significantly, which might be explained by suppressed Wnt/β-catenin signaling pathway and reversed Epithelial mesenchymal transformation (EMT) process. Collectively, our research identified a novel three-glycolysis-related lncRNA signature as a promising model for generating accurate prognoses for patients with ccRCC, and silencing lncRNA LINC00342 from the signature could partly inhibit the glycolysis level and migration of ccRCC cells.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QDQian Dou
Qian Dou
HTHang Tong
Hang Tong
YYYichun Yang
Yichun Yang
HZHan Zhang
Han Zhang
HGHua Gan
Hua Gan
We performed in vitro and in vivo experiments to explore the role of protein kinase C‐binding protein 1 (PICK1), an intracellular transporter involved in oxidative stress‐related neuronal diseases, in sepsis‐related acute kidney injury (AKI). Firstly, PCR, western blotting, and immunohistochemistry were used to observe the expression of PICK1 after lipopolysaccharide‐ (LPS‐) induced AKI. Secondly, by inhibiting PICK1 in vivo and silencing PICK1 in vitro, we further explored the effect of PICK1 on AKI. Finally, the relationship between PICK1 and oxidative stress and the related mechanisms were explored. We found that the expression of PICK1 was increased in LPS‐induced AKI models both in vitro and in vivo. PICK1 silencing significantly aggravated LPS‐induced apoptosis, accompanied by ROS production in renal tubular epithelial cells. FSC231, a PICK1‐specific inhibitor, aggravated LPS‐induced kidney injury. Besides, NAC (N‐acetylcysteine), a potent ROS scavenger, significantly inhibited the PICK1‐silencing‐induced apoptosis. In conclusion, PICK1 might protect renal tubular epithelial cells from LPS‐induced apoptosis by reducing excessive ROS, making PICK1 a promising preventive target in LPS‐induced AKI.

3 June 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
QDQian Dou
Qian Dou
SGShun Gao
Shun Gao
HGHua Gan
Hua Gan
ZKZhao Kang
Zhao Kang
HZHan Zhang
Han Zhang
HTHang Tong
Hang Tong
To explore the role of metastasis-related long noncoding RNA (lncRNA) signature for predicting the prognosis of clear cell renal cell carcinoma (ccRCC) patients. Firstly, metastasis-associated genes were identified to establish a metastasis-related lncRNA signature by statistical analysis. Secondly, the ccRCC patients were grouped into high-risk or low-risk group according to the established signature, and the different pathways between the 2 groups were identified by gene set enrichment analysis (GSEA). Finally, investigations involving PCR, transwell migration and invasion assay were carried out to further confirm our findings. The metastasis-related lncRNA signature was successfully constructed according to 7-metastasis-related genes (ADAM12, CD44, IL6, TFPI2, TGF-β1, THBS2, TIMP3). The diagnostic efficacy and the clinically predictive capacity of the signature were evaluated. Most of the values of the area under the time‐dependent receiver‐operating characteristic (ROC) were greater than 0.70. The nomogram constructed by integrating clinical data and risk scores confirmed that the risk score calculated from our signature was a good prognosis predictor. GSEA analysis showed that some tumor-related pathways were enriched in the high-risk group, while metabolism-related pathways were enriched in the low-risk group. In carcinoma tissues, the SSR3-6, WISP1-2 were highly expressed, but the expression of UBAC2-6 was low there. Knocking down SSR3-6 decreased the ability of migration and invasion in ccRCC cells. In conclusion, we successfully constructed a metastasis-related lncRNA signature, which could accurately predict the survival and prognosis of ccRCC patients.

21 August 2026 in Cancer Science
Verified
Journal Article
Open access
PDF file
JGJunlin Gan
Junlin Gan
XBXuesong Bai
Xuesong Bai
AZAijie Zhang
Aijie Zhang
FLFei Lin
Fei Lin
HTHang Tong
Hang Tong
HYHubin Yin
Hubin Yin
Tripartite motif‐containing 59 (TRIM59) is an E3 ubiquitin ligase implicated in multiple malignancies, but its role in bladder cancer (BLCA) remains incompletely understood. In this study, we identified TRIM59 as a clinically relevant oncogenic driver in BLCA through integrated transcriptomic, clinical, and functional analyses. TRIM59 was significantly upregulated in BLCA tissues and cell lines, and high TRIM59 expression was associated with advanced stage, higher grade, recurrence, and poor prognosis. Functionally, TRIM59 promoted BLCA proliferation, cell‐cycle progression, migration, invasion, and metastatic colonization in vitro and in vivo. Mechanistically, TRIM59 directly interacted with PTRF/Cavin‐1 and induced its RING domain‐dependent K48‐linked polyubiquitination and proteasomal degradation. Additional mutagenesis analyses identified K98, K122, K152, and K317 as major ubiquitination sites on PTRF. In contrast to the oncogenic role of TRIM59, PTRF was downregulated in BLCA and exhibited tumor‐suppressive properties. PTRF restoration attenuated TRIM59‐driven proliferation, invasion, and epithelial‐mesenchymal transition, whereas PTRF depletion partially rescued the inhibitory effects of TRIM59 silencing. Further analyses showed that PTRF restrains AKT phosphorylation and suppresses MYC transcriptional activity, thereby limiting c‐Myc‐driven proliferative signaling. Collectively, these findings define a previously unrecognized TRIM59–PTRF–AKT/c‐Myc axis that drives BLCA progression and highlight TRIM59 as a potential prognostic biomarker and therapeutic target.